Research advances in anti-Aβ targeted therapy for Alzheimer's disease:An update / 中华老年医学杂志

ABSTRACT

The theory of amyloid-induced Alzheimer's disease(AD) has been challenged by the scientific community.However,with the deep study of amyloid beta(Aβ)cascade metabolic reaction process and the characteristics and functions of various Aβ polypeptides,people have a profound understanding of the pathogenesis of AD caused by Aβ.Currently,several Aβ antibodies,including the protofibril selective antibody BAN2401,are in clinical trials for treating Alzheimer's disease.After the good results of targeted therapy for Aβ(Ban2401),this theory has attracted our attention again.In this paper,the pathogenesis of Aβ and the progress of targeted therapy were reviewed systematically.